Addition of testosterone to endocrine care for transgender women: a dose-finding and feasibility trial.
Noor C GielesMaurice A G M KroonStephanie BothAnnemieke C HeijboerBaudewijntje P C KreukelsMartin den HeijerPublished in: European journal of endocrinology (2024)
The use of testosterone supplementation in transgender women seems feasible and safe in the short term. Although dosing requires personalized titration, stable testosterone levels can be established. A blinded, placebo-controlled, randomized clinical trial is needed to study the clinical benefit.
Keyphrases
- replacement therapy
- placebo controlled
- polycystic ovary syndrome
- study protocol
- double blind
- phase iii
- phase ii
- healthcare
- pregnancy outcomes
- clinical trial
- cervical cancer screening
- palliative care
- breast cancer risk
- smoking cessation
- squamous cell carcinoma
- type diabetes
- skeletal muscle
- hepatitis c virus
- rectal cancer
- antiretroviral therapy